tirzepatide and vision New Research Confirms Weight-Loss Drug Link With Sudden Loss : ScienceAlert Vision loss: GLP-1 drugs like

Randomized placebo-controlled study comparing semaglutide with liraglutide and placebo in 957 non-diabetic, obese adults that showed greater weight loss with semaglutide compared with liraglutide

4 CVD is the leading cause of death in the U.S

5.2 Tirzepatide (SURMOUNT Trials) Tirzepatide demonstrated even greater mean weight loss in SURMOUNT trials. Findings included: Weight reductions exceeding 20% in some cohorts Dose-dependent gastrointestinal symptoms Lean mass reduction proportional to total weight loss Again, detailed micronutrient panels were not central trial endpoints

This study discusses the interplay between diabetes and insomnia, highlighting how each condition can influence the other

Even keeping them close to electronic devices that generate heat, such as laptops, is not recommended

Markers of HPA-axis activity and nucleic acid damage from oxidation after electroconvulsive stimulations in rats